ResearcherPage View Count

Geo Map
AS - Asia3102
NA - North America1550
EU - Europe1192
HKU - The University of Hong Kong473
AF - Africa229
OC - Oceania78
SA - South America18
UND - Undefined75
US - United States1532
CN - China1443
HK - Hong Kong540
KR - Republic of Korea515
HKU - The University of Hong Kong473
GB - United Kingdom462
SG - Singapore328
IE - Ireland280
NL - Netherlands170
ZA - South Africa159
OTH - Others815
The University of Hong Kong473
San Ramon162
Central District107
Treatment and Survival Outcomes in Women Treated with Malignant Ovarian Germ Cell Tumours95
Positive Surgical Margin At Cervical Conization For High-grade Squamous Intraepithelial Lesion: Does It Matter?45
Current Management of Gestational Trophoblastic Disease46
Comparison of Roche cobas test and HC2 test for the detection of high-risk HPV in a population-based study89
HBsAg Carrier Status and the Association Between Gestational Diabetes With Increased Serum Ferritin Concentration in Chinese Women15
Full karyotyping, rapid aneuploidy diagnosis or both when invasive prenatal testing is performed for diagnosis of thalassaemia?207
Is it a time for universal human papillomavirus vaccination in young women?14
Primary HPV testing with cytology versus cytology alone in cervical screening: a prospective randomised controlled trial (RCT) with 2 rounds of screening in a Chinese population 34
The role of regular physical examination in the detection of ovarian cancer recurrence232
Napsin A, Hepatocyte Nuclear Factor-1-Beta (HNF-1β), Estrogen and Progesterone Receptors Expression in Arias-Stella Reaction34
Immunotherapy in gynecological cancer 21
Reversed diastolic flow in the middle cerebral artery: Is it a terminal sign in a growth-retarded fetus?63
Malignant Transformation of Ovarian Mature Cystic Teratoma58
Patient compliance with cervical smear surveillance in a shared-care setting24
Placental site trophoblastic tumor: A distinct entity of gestational trophoblastic disease: Experience from a tertiary referral center in Hong Kong28
Debulking surgery for ovarian cancer22
Utility of phosphohistone H3 in uterine smooth muscle tumors: an Outcome-Based Assessment77
The impact of maternal HBsAg carrier status on pregnancy outcomes: A case-control study14
Vulval intraepithelial neoplasia33
Expression of napsin A in Arias Stella reaction: an analysis of 40 cases99
Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy35
Olaparib dose re-escalation in ovarian cancer patients who experienced severe and/or uncommon adverse events: A case series11
DWI predicts surgical outcome in advanced ovarian cancer27
DNA methylation status of oestrogen receptor beta(er-b) gene in ovarian cancer134
A Web-side Teaching Clinic in Obstetrics and Gynaecology during COVID-19 Pandemic17
Cervical carcinomas with serous-like papillary and micropapillary components: illustrating the heterogeneity of primary cervical carcinomas37
Research in gynaecological cancers38
Successful Treatment of a Pararenal Pregnancy Using High-Dose Methotrexate Regimen: A Case Report73
COVID‐19 and gynecological cancers: Asia and Oceania Federation of Obstetrics and Gynecology oncology committee opinion7
Surgicopathological prognostic parameters in uterine leiomyosarcoma: an Asian Gynecologic Oncology Group and collaborator study34
Hémangiome vulvaire34
Identification of novel methylated genes in patients with endometrial cancers262
Improvement of drug efficacy of polo-like kinase 4 inhibitor in the treatment of uterine leiomyosarcoma33
Differentiation of aggressive and indolent subtypes of uterine sarcoma using maximum standardized uptake value90
The use of vaginal antimicrobial after large loop excision of transformation zone: A prospective randomised trial241
Vulval Hemangioma60
Current concepts in the management of endometrial carcinoma130
Gestational trophoblastic disease47
Molecular Imaging of Peritoneal Carcinomatosis in Ovarian Carcinoma25
Maternal hepatitis B infection and gestational diabetes mellitus>21
Predictive biomarkers and tumor microenvironment in female genital melanomas: a multi-institutional study of 55 cases79
Clinical presentation of clear cell carcinoma of the ovary103
Placental Site Trophoblastic Tumor: A Distinct Entity of Gestational Trophoblastic Disease Experience from a Tertiary Referral Center in Hong Kong12
MRI texture features differentiate clinicopathological characteristics of cervical carcinoma28
Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: A review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy75
A case series of gestational epithelioid trophoblastic tumors (ETT)26
World trends of incidence of gynecologic malignancies in young women21
Diffusion Kurtosis Imaging in the Assessment of Cervical Carcinoma36
Staging of uterine sarcomas143
Experience of using bevacizumab in epithelial ovarian, fallopian tube and primary peritoneal cancers in a single centre64
Tamoxifen use in recurrent ovarian cancer in a Chinese population: A 15 ‐year clinical experience in a tertiary referral center28
Recent Advances in the Management of Primary Epithelial Ovarian Cancer22
Prevention of cervical cancer – HPV vaccines16
Relationship between intravoxel incoherent motion diffusion-weighted MRI and dynamic contrast-enhanced MRI in tissue perfusion of cervical cancers82
Female Genital melanomas: A clinicopathologic and PD-L1 expression study83
Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer5
Poor prognosis associated with venous thromboembolism in Asian patients with ovarian clear cell carcinoma32
Quality-of-life of ovarian cancer patients with prolonged use of chemotherapy - a prospective comparative quantitative and qualitative study56
Diffusion-weighted magnetic resonance imaging of primary cervical cancer in the detection of sub-centimetre metastatic lymph nodes66
SUVmax distinguishes the aggressive from the indolent subtypes of uterine sarcoma46
Role of lymphadenectomy and vincristine, actinomycin-D, and cyclophosphamide chemotherapy in malignant ovarian germ cell tumors101
Advance in the use of PARPi in ovarian cancer after the SGO19
Nurse-led follow-up in survivorship care of gynaecological malignancies-A randomised controlled trial41
An update on gestational trophoblastic disease67
Role of metformin on cell proliferation and apoptosis in cervical cancer32
The impact of tumour burden derived from diffusion-weighted imaging on surgical complexity in primary advanced ovarian cancer25
Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma68
Epigenetic alteration of the metallothionein 1e gene in human endometrial carcinomas191
Malignant Ovarian Germ Cell Tumour: The Role of Lymphadenectomy and VAC Chemotherapy50
The role of physical examination in the routine follow up of patients treated for ovarian carcinoma94
The use of PARPi in primary advanced ovarian cancer10
The Role of Regular Clinical Follow Up of Gynaecological Oncology Patients - a randomised controlled trial 108
The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based study52
A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage190
Ovarian vein thrombosis in a patient with recurrent ovarian cancer17
Vaginal Intraepithelial Neoplasia159
The role of laparoscopy in staging of different gynaecological cancers67
Adjuvant and post-surgical treatment in non-epithelial ovarian cancer5
Gestational trophoblastic disease124
Evaluation of potential immunotherapy biomarkers in female genital tract malignant melanomas33
Evaluation of potential immunotherapy biomarkers in female genital tract malignant melanomas31
A Case Series of Five Patients With Pure or Mixed Gestational Epithelioid Trophoblastic Tumors and a Literature Review on Mixed Tumors64
Impact of different educational interventions on psychosocial well-being of women with a positive high-risk human papillomavirus and normal cervical cytology: a randomised trial34
Multi-disciplinary team practice for ovarian cancer in Hong Kong12
Cervical Cancer Prevention83
Robot-assisted gynaecological cancer surgery—complications and prevention32
Intraoperative Frozen Section Biopsy of Uterine Smooth Muscle Tumors5
Uterine Arteriovenous Malformations Following Choriocarcinoma. 19
Shared care system for patients with abnormal cervical smear results between a colposcopy centre and a community centre98
Disappearing Uterine Carcinosarcoma Following Uterine Artery Embolisation24
Local experience of the management of profuse bleeding in gestational trophoblastic diseases97
Ataxia–Telangiectasia Mutated (ATM) Protein Expression in Uterine Smooth Muscle Tumors36
Primary HPV testing with cytology versus cytology alone in cervical screening—A prospective randomized controlled trial with two rounds of screening in a Chinese population74
Olaparib mediated DNA damage response and its resistant mechanism in cervical cancer cells29
Cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine in the treatment of gestational trophoblastic neoplasia78
A case report: Diagnostic and treatment difficulty in a patient with retroperitoneal pregnancy136
Current management of gestational trophoblastic disease23
Uterine Blood Flow Analysis for Predicting Gestational Trophoblastic Neoplasia in Women with Hydatidiform Mole Using Three-Dimensional Power Doppler Ultrasound54
Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia203
The Value of Contrast-Enhanced CT in the Detection of Residual Disease After Neo-Adjuvant Chemotherapy in Ovarian Cancer24
Comparison of different staging systems for high-grade uterine leiomyosarcoma28
Human papillomavirus and cervical cancer23
COVID-19 and Gynaecological Cancer Management: Chemotherapy, Targeted Therapy, and Immunotherapy9
Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer87
Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface177
Development of a Multi-Institutional Prediction Model for Three-Year Survival Status in Patients with Uterine Leiomyosarcoma (AGOG11-022/QCGC1302 Study)13
Bevacizumab in Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer: A Single Centre Experience66
Recurrent Gestational Trophoblastic Neoplasia with Pulmonary Metastatic Choriocarcinoma: A Case Report76